Solute carrier family 2, facilitated glucose transporter member 3

BE0004707ProteinHumansSLC2A3

Facilitative glucose transporter (PubMed:26176916, PubMed:32860739, PubMed:9477959). It is acted on by 7 drugs in DrugBank.

Gene name
SLC2A3
UniProtKB entry
P11169Swiss-Prot
Cellular location
Cell membrane
Residues / weight
496 residues · 53,924 Da
Also known as
Glucose transporter type 3, brain · GLUT-3 · GLUT3

Resolves to

Protein
UniProtP11169UniProt nameGTR3_HUMAN
Gene
HGNCHGNC:11007NCBI Gene6515GeneCardsSLC2A3
Pharmacology
KEGGhsa:6515
Structure
PDB4ZW9PDB4ZWBPDB4ZWC
Drugs

What you can answer from here — as of September 07, 2019

7DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
2Clinical trialsTrials of drugs acting on it, by phase and status
Sign in
15GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
15+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Solute carrier family 2, facilitated glucose transporter member 3, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In